Prediabetes
Conditions
Interventions
Study setting: This study will be conducted at Maga Medical Complex/Armed Forces Institutes of Pathology (AFIP), National University of Medical Sciences Rawalpindi, Pakistan.
Randomization: The pred
Sponsors
National University of Medical Sciences Rawalpindi, Pakistan.
Eligibility
Inclusion criteria
Inclusion criteria: * Both men and women * Aged 18-60 years * Participants who are diagnosed to have Prediabetic criteria: a. Impaired fasting plasma glucose level (5.6-6.9mmol/L) or/and b. Glycosylated hemoglobin (HbA1c) 5.7% to 6.4%
Exclusion criteria
Exclusion criteria: 1.Cardiac patients 2.Pregnant or breast-feeding females 3.Critically ill patients 4. Acute stress/anxiety 5.Severe renal, liver or respiratory disease 5.Cancer patients 6.Those taking any medicine for glucose control
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1.Improvement of glycemic control including mean reduction in measurement of fasting plasma glucose (mmol/L) and HbA1c (mmol/L) at 12 weeks with baseline values [At the baseline of the study and at 12 weeks after Delta-Tocotrienol supplementation (NS).] | — |
Secondary
| Measure | Time frame |
|---|---|
| Mean reduction in insulin resistance by measuring fasting blood glucose, (mmol/L), serum insulin (IU/L) and Homeostatic Model Assessment of Insulin Resistance (HOMA IR). [At the baseline of the study and at 12 weeks after Delta-Tocotrienol supplementation (NS).] | — |
Countries
Pakistan
Contacts
Public ContactDr. Dilshad Ahmed Khan
Professor of Pathology
Outcome results
None listed